Dr. Larry Schlesinger, president and CEO of Texas Biomedical Research Institute, says Texas is in a critical time now to get the virus under control as ...
News
- Some San Antonio COVID-19 survivors appalled by Gov. Abbott's decision to reopen state without ...
- FibroGen, 3D Systems fall; Kontoor Brands, Square rise
The biotechnology company's fourth-quarter loss was bigger than Wall Street had forecast. Zoom Video Communications Inc., down $36.87 to $372.79 ...
- Ukraine's leader gets vaccine shot to dispel public doubts
The country also signed an agreement to purchase 1.9 million doses from China's Sinovac Biotech. Speaking in parliament, Oleksandr Kornienko, ...
- Nasal Spray Reduces COVID-19 Symptoms
Currently scientists from Lancaster University in England and Texas Biomedical Research Institute in San Antonio are working on a nasal spray to ...
- GlycoMimetics: 4Q Earnings Snapshot
The biotechnology company posted revenue of $163,000 in the period. For the year, the company reported that its loss narrowed to $51 million, ...